<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01778166</url>
  </required_header>
  <id_info>
    <org_study_id>ISEEN001</org_study_id>
    <secondary_id>ISEEN</secondary_id>
    <nct_id>NCT01778166</nct_id>
  </id_info>
  <brief_title>Gastrointestinal Postoperative Early Enteral Nutrition: Immuno-enhanced Versus Standard Early Enteral Nutrition</brief_title>
  <acronym>ISEEN</acronym>
  <official_title>Immuno-enhanced Versus Standard Early Enteral Nutrition Use in Gastrointestinal Postoperative Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jinling Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Natural Science Foundation of China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Jinling Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with gastrointestinal(GI) malignancy usually suffer from malnutrition and suppressed
      immune function, which might be worsened by major elective surgery.Enteral nutrition has been
      emphasized for patients with GI malignancy during the perioperative period to accelerate
      bowel function recovery, and improve nitrogen balance and immune response while reducing
      postoperative complications and hospitalization time.Early enteral nutrition(EEN) can promote
      the postoperative recovery of GI function and has been considered to have other advantages
      such as the reduction of medical cost and maintenance of intestinal barrier function.
      Immunonutrition containing special compounds like omega-3-unsaturated fatty acids has been
      put forward to modulate the immune response and improve the immune function in patients with
      cancer, which may have an better effect on the immune system than standard enteral nutrition.
      However, studies on immuno-enhanced early enteral nutrition after a resectable GI malignancy
      surgery are scarce.

      The aim of this study was to determine whether immuno-enhanced early enteral nutrition(IEEN)
      is more effective than standard early enteral nutrition(SEEN) on nutritional status, immune
      function, surgical outcomes,time to adjuvant chemotherapy and days of hospitalization after
      laparoscopic GI surgery.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to tolerate IEEN/SEEN</measure>
    <time_frame>30 days after operation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall morbidity rate of IEEN/SEEN</measure>
    <time_frame>60 days after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality rate of IEEN/SEEN after operation</measure>
    <time_frame>60 days after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Energy metabolism</measure>
    <time_frame>10 days after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to the first postoperative adjuvant chemotherapy</measure>
    <time_frame>30 days after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nutritional status in postoperative day1and 7 of IEEN/SEEN</measure>
    <time_frame>7 days after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immune function in postoperative day 1 and 7</measure>
    <time_frame>7 days after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative hospital stay length</measure>
    <time_frame>60 days after operation</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rehospitalization rate</measure>
    <time_frame>30 days after discharge</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Gastrointestinal Malignant</condition>
  <arm_group>
    <arm_group_label>Standard early enteral nutrition</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>There would be 100 patients in this group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Immuno-enhanced early enteral nutrition</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>There would 100 patients in this group</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Immuno-enhanced</intervention_name>
    <description>Immediately drip 37째C saline 20 ml/h and exchange to drip 37째C enteral nutrition fluid concerning omega-3-unsaturated fatty acids 20 ml/h at postoperative 6 h via jejunostomy tube or nasogastric tube</description>
    <arm_group_label>Immuno-enhanced early enteral nutrition</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard early enteral nutrition</intervention_name>
    <description>Immediately drip 37째C saline 20 ml/h and exchange to drip 37째C standard enteral nutrition fluid 20 ml/h at postoperative 6 h via jejunostomy tube or nasogastric tube</description>
    <arm_group_label>Standard early enteral nutrition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Resectable gastric cancer by laparoscope

          -  Resectable colorectal cancer laparoscope

          -  Resectable gastrointestinal interstitialoma by laparoscope

        Exclusion Criteria:

          -  Locally unresectable tumor

          -  Metastatic tumor

          -  Preoperative total parenteral or enteral nutrition

          -  Lack of the patient's consent for the trial participation

          -  Previous gastrointestinal resection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Danhua Yao, MD/PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nanjing University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Danhua Yao, MD/PhD</last_name>
    <phone>8602580860961</phone>
    <email>yaodh87@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yousheng Li, MD/PhD</last_name>
    <phone>8602580860137</phone>
    <email>liys@medmail.com.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jinling Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Danhua Yao, MD/PhD</last_name>
      <phone>8602580860037</phone>
    </contact>
    <investigator>
      <last_name>Danhua Yao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Osland E, Yunus RM, Khan S, Memon MA. Early versus traditional postoperative feeding in patients undergoing resectional gastrointestinal surgery: a meta-analysis. JPEN J Parenter Enteral Nutr. 2011 Jul;35(4):473-87. doi: 10.1177/0148607110385698. Epub 2011 May 31.</citation>
    <PMID>21628607</PMID>
  </reference>
  <reference>
    <citation>Liu H, Ling W, Shen ZY, Jin X, Cao H. Clinical application of immune-enhanced enteral nutrition in patients with advanced gastric cancer after total gastrectomy. J Dig Dis. 2012 Aug;13(8):401-6. doi: 10.1111/j.1751-2980.2012.00596.x.</citation>
    <PMID>22788925</PMID>
  </reference>
  <reference>
    <citation>Felekis D, Eleftheriadou A, Papadakos G, Bosinakou I, Ferekidou E, Kandiloros D, Katsaragakis S, Charalabopoulos K, Manolopoulos L. Effect of perioperative immuno-enhanced enteral nutrition on inflammatory response, nutritional status, and outcomes in head and neck cancer patients undergoing major surgery. Nutr Cancer. 2010;62(8):1105-12. doi: 10.1080/01635581.2010.494336.</citation>
    <PMID>21058198</PMID>
  </reference>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2013</study_first_submitted>
  <study_first_submitted_qc>January 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2013</study_first_posted>
  <last_update_submitted>January 30, 2013</last_update_submitted>
  <last_update_submitted_qc>January 30, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Jinling Hospital, China</investigator_affiliation>
    <investigator_full_name>Danhua Yao</investigator_full_name>
    <investigator_title>Senior Resident</investigator_title>
  </responsible_party>
  <keyword>Early enteral nutrition</keyword>
  <keyword>Laparoscopic gastrointestinal surgery</keyword>
  <keyword>Immuno-enhanced nutrition</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

